cytomegalovirus infection
cytomegalovirus infection
Explore linked clinical trials. Standard reference: MONDO:000513257 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT03354728 | |
| Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-24 | NCT06066957 | |
| Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone | DNA Virus Infections, Herpesviridae infectious disease, Infections, adenoviridae infectious disease, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 3 | 2026-09-11 | NCT07225972 | |
| CMV Refractory and Resistant Infection in Solid Organ Transplant Recipients in Argentina | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Not yet recruiting | Not stated | 2026-08-26 | NCT07787767 | |
| Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection | DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Site, cytomegalovirus infection, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm, viral infectious disease | Active, not recruiting | Phase 2 | 2026-08-18 | NCT02210078 | |
| Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study | DNA Virus Infections, Herpesviridae infectious disease, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Varicella Zoster Virus Infection, chickenpox, cytomegalovirus infection, viral infectious disease | Active, not recruiting | Not stated | 2026-08-12 | NCT05532540 | |
| Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II | DNA Virus Infections, Herpesviridae infectious disease, Infections, anterior uveitis, cytomegalovirus infection, eye disorder, panuveitis, uveal disorder, uveitis, viral infectious disease | Not yet recruiting | Phase 2 | 2026-08-11 | NCT07513623 | |
| CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Enrolling by invitation | Phase 4 | 2026-08-10 | NCT07009548 | |
| A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. | DNA Virus Infections, Herpesviridae infectious disease, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, cytomegalovirus infection, herpes simplex infectious disease, skin disorder, skin disorder caused by infection, viral infectious disease | Active, not recruiting | Phase 2 | 2026-08-10 | NCT05683457 | |
| Study Evaluating the Efficacy and Safety of Artesunate | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 2 | 2026-08-03 | NCT06853184 | |
| R-MVST Cells for Treatment of Viral Infections in Children and Young Adults | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, adenoviridae infectious disease, cytomegalovirus infection, immune system disorder, inborn error of immunity, viral infectious disease | Recruiting | Phase 1 | 2026-07-30 | NCT06926894 | |
| Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant | B-cell chronic lymphocytic leukemia, Chronic Disease, DNA Virus Infections, Disease Attributes, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Hodgkins lymphoma, Infections, Leukemia, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Lymphadenopathy, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, bone marrow disorder, cytomegalovirus infection, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, leukemia, myeloid, accelerated-phase, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, myeloproliferative neoplasm, neoplasm, non-Hodgkin lymphoma, primary myelofibrosis, viral infectious disease | Active, not recruiting | Phase 2 | 2026-07-28 | NCT02506933 | |
| CMV-CMI in csCMVi After HSCT | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Not stated | 2026-07-07 | NCT07688759 | |
| Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Not applicable | 2026-07-06 | NCT07685457 | |
| Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis. | DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Site, autoimmune disease, cytomegalovirus infection, cytomegalovirus retinitis, eye disorder, eye infectious disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, neoplasm, retinal disorder, retinitis, viral eye infection, viral infectious disease | Recruiting | Not applicable | 2026-07-01 | NCT07679412 | |
| Anti-viral T-cell Therapy by Gamma Capture | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, adenoviridae infectious disease, cytomegalovirus infection, viral infectious disease | Enrolling by invitation | Phase 1 / Phase 2 | 2026-06-29 | NCT06027879 | |
| Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2026-06-26 | NCT07670468 | |
| Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Herpesviridae infectious disease, Infections, Nutritional and Metabolic Diseases, cytomegalovirus infection, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, inborn mitochondrial metabolism disorder, metabolic disease, multiple acyl-CoA dehydrogenase deficiency, viral infectious disease | Recruiting | Not stated | 2026-06-15 | NCT05234723 | |
| Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 3 | 2026-06-11 | NCT06407232 | |
| R-MVST Cells for Treatment of Viral Infections | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, adenoviridae infectious disease, cytomegalovirus infection, viral infectious disease | Recruiting | Phase 1 | 2026-06-10 | NCT05183490 | |
| Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection | DNA Virus Infections, Ear Diseases, Hearing Loss, Sensorineural, Herpesviridae infectious disease, Infections, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, cytomegalovirus infection, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease, viral infectious disease | Recruiting | Not stated | 2026-06-09 | NCT07635368 | |
| Evaluation of Software for Interpreting Virological Results Indicated for the Diagnosis of Cytomegalovirus (CMV) Infection During Pregnancy and Intended for Health Professionals | DNA Virus Infections, Herpesviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cytomegalovirus infection, disease, viral infectious disease | Recruiting | Not stated | 2026-06-08 | NCT06694428 | |
| Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, graft versus host disease, immune system disorder, viral infectious disease | Recruiting | Phase 4 | 2026-06-01 | NCT07569653 | |
| Letermovir vs Valganciclovir in CMV R+ Kidney Transplant | Cytopenia, DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, agranulocytosis, cytomegalovirus infection, hematologic disorder, leukocyte disorder, leukopenia, neutropenia, viral infectious disease | Not yet recruiting | Phase 4 | 2026-05-08 | NCT07571135 | |
| HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial | DNA Virus Infections, Herpesviridae infectious disease, Infections, cytomegalovirus infection, viral infectious disease | Not yet recruiting | Phase 4 | 2026-05-06 | NCT07570433 |